Literature DB >> 8470428

Vaccination of mice against canine distemper virus-induced encephalitis with vaccinia virus recombinants encoding measles or canine distemper virus antigens.

T F Wild1, A Bernard, D Spehner, D Villeval, R Drillien.   

Abstract

Measles and canine distemper are caused by serologically related viruses. Although dogs immunized with measles virus (MV) do not elicit canine distemper virus (CDV) neutralizing antibodies, they are protected against the fatal disease. To investigate the potential role of the MV antigens in protection against CDV, we have immunized mice with vaccinia virus (VV) recombinants expressing the MV haemagglutinin (HA), fusion (F), nucleoprotein (NP) and matrix (M) antigens and challenged them with CDV. A partial protection was observed with the VV recombinants expressing the F, NP and M antigens, but not the HA. In contrast, immunization with a VV recombinant expressing the CDV F protein completely protected mice from CDV.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8470428     DOI： 10.1016/0264-410x(93)90285-6

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


  11 in total

1.  Measles virus assembly within membrane rafts.

Authors:  S Vincent; D Gerlier; S N Manié
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Alteration of the leptin network in late morbid obesity induced in mice by brain infection with canine distemper virus.

Authors:  A Bernard; R Cohen; S T Khuth; B Vedrine; O Verlaeten; H Akaoka; P Giraudon; M F Belin
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

3.  Canine distemper virus (CDV) infection of ferrets as a model for testing Morbillivirus vaccine strategies: NYVAC- and ALVAC-based CDV recombinants protect against symptomatic infection.

Authors:  C B Stephensen; J Welter; S R Thaker; J Taylor; J Tartaglia; E Paoletti
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

4.  Vaccination against canine distemper virus infection in infant ferrets with and without maternal antibody protection, using recombinant attenuated poxvirus vaccines.

Authors:  J Welter; J Taylor; J Tartaglia; E Paoletti; C B Stephensen
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

5.  Effect of immunization with plasmid DNA encoding for rinderpest virus matrix protein on systemic rinderpest virus infection in rabbits.

Authors:  B Pahar; B Sharma; A C Goel
Journal:  Vet Res Commun       Date:  2002-04       Impact factor: 2.459

6.  Measles virus fusion: role of the cysteine-rich region of the fusion glycoprotein.

Authors:  T F Wild; J Fayolle; P Beauverger; R Buckland
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

7.  Protection against morbillivirus-induced encephalitis by immunization with a rationally designed synthetic peptide vaccine containing B- and T-cell epitopes from the fusion protein of measles virus.

Authors:  O E Obeid; C D Partidos; C R Howard; M W Steward
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

8.  Development of a dual recombinant vaccine to protect small ruminants against peste-des-petits-ruminants virus and capripoxvirus infections.

Authors:  G Berhe; C Minet; C Le Goff; T Barrett; A Ngangnou; C Grillet; G Libeau; M Fleming; D N Black; A Diallo
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

9.  Functional and structural interactions between measles virus hemagglutinin and CD46.

Authors:  O Nussbaum; C C Broder; B Moss; L B Stern; S Rozenblatt; E A Berger
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

Review 10.  Recombinant vaccines against the mononegaviruses--what we have learned from animal disease controls.

Authors:  Hiroki Sato; Misako Yoneda; Tomoyuki Honda; Chieko Kai
Journal:  Virus Res       Date:  2011-10-05       Impact factor: 3.303
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.